Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine vs Bismuth Quadruple Therapy for H. pylori Eradication
NCT02296021Phase 4Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Nov 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of berberine in Helicobacter pylori infection (2 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: Helicobacter pylori eradication. Started Nov 2014; status: completed.
02
Drugs
berberine
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02296021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02296021.